Perth listed company Resonance Health Limited has expanded its medical advisory board with three new appointments. The board will assist the company’s aim of establishing its product FerriScan as a definitive tool for non-invasive liver iron measurement.
The three new appointments are:
• St Louis University School of Medicine director of gastroenterology and hepatology Bruce Bacon;
• University of WA School of Medicine and Pharmacology professor of gastroenterology John Olynyk; and
• University College London professor of haematology John Porter.